The present invention relates to a method for alleviation, prevention, and treatment of attention deficit disorder, sexual dysfunction, and related conditions by administering certain bioactive metabolites of the known anti-depressant compound gepirone. In a preferred embodiment, the compound is 4,4,-dimethyl-3-hydroxy-l-[4-[4-(2-pyrimidinyl)-l- piperazinyl]butyl]-2,6-piperidinedione (3-OH gepirone).